Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

NCT01924624 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Recurrence

Interventions

DRUG: Thalidomide

Sponsor

The First Affiliated Hospital of Xiamen University